Selective Participation of C-Jun With Fra-2/C-Fos Promotes Aggressive Tumor Phenotypes and Poor Prognosis in Tongue Cancer

Scientific Reports - United Kingdom
doi 10.1038/srep16811
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Overexpression of P62 Is Associated With Poor Prognosis and Aggressive Phenotypes in Osteosarcoma

Oncology Letters
Cancer ResearchOncology
2018English

Chemokine (C-X-C Motif) Ligand 1 (CXCL1) Is Associated With Tumor Progression and Poor Prognosis in Patients With Colorectal Cancer

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2018English

ERO1α Promotes Hypoxic Tumor Progression and Is Associated With Poor Prognosis in Pancreatic Cancer

Oncotarget
Oncology
2019English

In SituProximity Ligation Detection of C-Jun/Ap-1 Dimers Reveals Increased Levels of C-Jun/Fra1 Complexes in Aggressive Breast Cancer Cell Linesin Vitroandin Vivo

Molecular and Cellular Proteomics
BiochemistryMedicineAnalytical ChemistryMolecular Biology
2010English

Tumor Budding Correlates With Poor Prognosis and Epithelial-Mesenchymal Transition in Tongue Squamous Cell Carcinoma

Journal of Oral Pathology and Medicine
Cancer ResearchOral SurgeryOtorhinolaryngologyForensic MedicinePathologyPeriodontics
2011English

Conformation of the C-Fos/C-Jun Complex in Vivo: A Combined FRET, FCCS, and MD-Modeling Study

Biophysical Journal
Biophysics
2008English

Long Non‑coding RNA XIST Predicts Poor Prognosis and Promotes Malignant Phenotypes in Osteosarcoma

Oncology Letters
Cancer ResearchOncology
2018English

G12 Signaling Through C-Jun NH2-Terminal Kinase Promotes Breast Cancer Cell Invasion

PLoS ONE
Multidisciplinary
2011English

Protein Kinases C-Beta and C-Epsilon Link the Mast Cell High-Affinity Receptor for IgE to the Expression of C-Fos and C-Jun.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1994English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy